Evidence map›Paper›PMID 28092348›Full record

Trial reportBone marrow transplantation2017

Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission.

W-Z Cai, J-N Cen, J Chen, F Chen, C-C Fu, Y Han, Z-M Jin, X Ma, M Miao, H-Y Qiu and 5 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

W-Z CaiJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
J-N CenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
J ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
F ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
C-C FuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Y HanJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Z-M JinJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
X MaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
M MiaoJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
H-Y QiuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
X-W TangJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
S-L XueJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
A-N SunJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
S-N ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
D-P WuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationPhiladelphia ChromosomePrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultAllograftsDisease-Free SurvivalFemaleFollow-Up StudiesHumansMaleMiddle AgedSurvival Rate

Identifiers

PMID28092348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.